Revised guidelines published by EMA and HMA update the rules on identification of commercially confidential information and personal data used in marketing authorization applications.

Innovation, Collaboration, and Performance Were Highlights for EMA in 2024

By Susan Haigney

December 24th 2024

Emer Cooke, executive director of EMA, is encouraged by the competitiveness of the European pharmaceutical market.

Electronic Product Information Moves Forward in Europe

By Susan Haigney

December 17th 2024

A pilot program to explore creation and testing of ePIs in regulatory procedures shows positive results.

Several Orphan Drugs Among Medicines Recommended for Approval by EMA in December

By Susan Haigney

December 16th 2024

EMA recommended 17 drugs for marketing authorization in December, including treatments for rare heart conditions, anemia, and liver disease.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Novo Nordisk Gains Manufacturing Sites from Novo Holdings and Novavax while EC Approves Catalent Acquisition

By Feliza Mirasol

December 11th 2024

The European Commission has approved Novo Holdings' acquisition of Catalent, which includes the related sale of three manufacturing sites to Novo Nordisk, which is also acquiring the Czech Republic manufacturing site of Novavax for $200 million.

...

23 24 25 26 27

About Us

Advertise

Editorial Info

Editorial Advisory Board

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777